계정 가입
email 로 로그인
email 로 가입
수신함을 확인하세요
ValenzaBio
About
ValenzaBio is developing safe and effective treatment options for patients with autoimmune and inflammatory diseases.
- 11 - 50
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $79.37M
- Industries
- Biopharma,Biotechnology,Health Care,Pharmaceutical
- Founded date
- Jan 1, 2019
- Number Of Employee
- 11 - 50
- Operating Status
- Active
ValenzaBio is developing safe and effective treatment options for patients with autoimmune and inflammatory diseases.ValenzaBio implements biomarker-driven approaches to guide research and clinical development. Our pipeline includes several monoclonal antibodies targeting surface antigens to reduce pathogenic subpopulations of autoreactive cells. Our most advanced program has generated Phase 1 proof-of-concept in patients and we’re progressing preclinical programs focused on differentiated mechanisms of action. Our mission is to provide safe and effective treatment options for patients with unmet needs.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 8, 2021 | Series A | $79.37M | 1 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series A |
